US Stock MarketDetailed Quotes

Entera Bio (ENTX)

Watchlist
  • 1.300
  • -0.070-5.11%
Close May 8 15:59 ET
  • 1.300
  • 0.0000.00%
Post 19:27 ET
63.99MMarket Cap-5.00P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Entera Bio (ENTX) Income Statement

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Total revenue
0
-76.80%42K
0
0
0
42K
181K
82K
42K
57K
Operating revenue
--0
-76.80%42K
--0
--0
--0
--42K
--181K
--82K
--42K
--57K
Cost of revenue
0
-75.58%42K
0
0
0
42K
172K
82K
42K
48K
Gross profit
0
0
0
0
0
0
9K
0
0
9K
Operating expense
38.08%3.54M
20.17%11.53M
30.17%3.04M
7.78%3.26M
22.72%2.67M
24.30%2.56M
7.91%9.59M
19.05%2.34M
26.61%3.02M
-6.70%2.17M
Selling and administrative expenses
-10.56%1.29M
8.44%5.53M
16.55%1.32M
4.47%1.61M
5.51%1.15M
8.52%1.44M
15.01%5.1M
16.75%1.14M
50.19%1.54M
-4.14%1.09M
-General and administrative expense
-10.56%1.29M
8.44%5.53M
16.55%1.32M
4.47%1.61M
5.51%1.15M
8.52%1.44M
15.01%5.1M
16.75%1.14M
50.19%1.54M
-4.14%1.09M
Research and development costs
100.45%2.25M
33.45%6M
43.05%1.72M
11.24%1.64M
39.96%1.52M
52.79%1.12M
-0.24%4.5M
20.10%1.2M
7.81%1.48M
-10.17%1.09M
Operating profit
-38.08%-3.54M
-20.28%-11.53M
-30.17%-3.04M
-7.78%-3.26M
-23.23%-2.67M
-24.30%-2.56M
-7.81%-9.59M
-19.05%-2.34M
-26.61%-3.02M
7.08%-2.17M
Net non-operating interest income expense
950.00%34K
55.17%90K
471.43%26K
56K
-40.00%12K
-108.89%-4K
87.10%58K
78.13%-7K
0
300.00%20K
Non-operating interest income
--34K
----
----
----
-40.00%12K
----
----
----
----
--20K
Total other finance cost
----
-55.17%-90K
-471.43%-26K
---56K
----
108.89%4K
-87.10%-58K
-78.13%7K
----
-300.00%-20K
Other net income (expense)
Income before tax
-36.54%-3.51M
-20.07%-11.44M
-28.67%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.53%-9.53M
-17.49%-2.34M
-28.55%-3.02M
7.74%-2.15M
Income tax
0
-51.72%14K
14K
0
Net income
-36.54%-3.51M
-19.89%-11.44M
-27.91%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.33%-9.54M
-18.20%-2.36M
-26.99%-3.02M
7.74%-2.15M
Net income continuous Operations
-36.54%-3.51M
-19.89%-11.44M
-27.91%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.33%-9.54M
-18.20%-2.36M
-26.99%-3.02M
7.74%-2.15M
Minority interest income
Net income attributable to the parent company
-36.54%-3.51M
-19.89%-11.44M
-27.91%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.33%-9.54M
-18.20%-2.36M
-26.99%-3.02M
7.74%-2.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-36.54%-3.51M
-19.89%-11.44M
-27.91%-3.02M
-5.93%-3.2M
-23.82%-2.66M
-27.27%-2.57M
-7.33%-9.54M
-18.20%-2.36M
-26.99%-3.02M
7.74%-2.15M
Basic earnings per share
-16.67%-0.07
0.00%-0.25
-16.67%-0.07
12.50%-0.07
0.00%-0.06
-20.00%-0.06
19.35%-0.25
14.29%-0.06
0.00%-0.08
25.00%-0.06
Diluted earnings per share
-16.67%-0.07
0.00%-0.25
-16.67%-0.07
12.50%-0.07
0.00%-0.06
-20.00%-0.06
19.35%-0.25
14.29%-0.06
0.00%-0.08
25.00%-0.06
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Total revenue 0-76.80%42K00042K181K82K42K57K
Operating revenue --0-76.80%42K--0--0--0--42K--181K--82K--42K--57K
Cost of revenue 0-75.58%42K00042K172K82K42K48K
Gross profit 0000009K009K
Operating expense 38.08%3.54M20.17%11.53M30.17%3.04M7.78%3.26M22.72%2.67M24.30%2.56M7.91%9.59M19.05%2.34M26.61%3.02M-6.70%2.17M
Selling and administrative expenses -10.56%1.29M8.44%5.53M16.55%1.32M4.47%1.61M5.51%1.15M8.52%1.44M15.01%5.1M16.75%1.14M50.19%1.54M-4.14%1.09M
-General and administrative expense -10.56%1.29M8.44%5.53M16.55%1.32M4.47%1.61M5.51%1.15M8.52%1.44M15.01%5.1M16.75%1.14M50.19%1.54M-4.14%1.09M
Research and development costs 100.45%2.25M33.45%6M43.05%1.72M11.24%1.64M39.96%1.52M52.79%1.12M-0.24%4.5M20.10%1.2M7.81%1.48M-10.17%1.09M
Operating profit -38.08%-3.54M-20.28%-11.53M-30.17%-3.04M-7.78%-3.26M-23.23%-2.67M-24.30%-2.56M-7.81%-9.59M-19.05%-2.34M-26.61%-3.02M7.08%-2.17M
Net non-operating interest income expense 950.00%34K55.17%90K471.43%26K56K-40.00%12K-108.89%-4K87.10%58K78.13%-7K0300.00%20K
Non-operating interest income --34K-------------40.00%12K------------------20K
Total other finance cost -----55.17%-90K-471.43%-26K---56K----108.89%4K-87.10%-58K-78.13%7K-----300.00%-20K
Other net income (expense)
Income before tax -36.54%-3.51M-20.07%-11.44M-28.67%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.53%-9.53M-17.49%-2.34M-28.55%-3.02M7.74%-2.15M
Income tax 0-51.72%14K14K0
Net income -36.54%-3.51M-19.89%-11.44M-27.91%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.33%-9.54M-18.20%-2.36M-26.99%-3.02M7.74%-2.15M
Net income continuous Operations -36.54%-3.51M-19.89%-11.44M-27.91%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.33%-9.54M-18.20%-2.36M-26.99%-3.02M7.74%-2.15M
Minority interest income
Net income attributable to the parent company -36.54%-3.51M-19.89%-11.44M-27.91%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.33%-9.54M-18.20%-2.36M-26.99%-3.02M7.74%-2.15M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -36.54%-3.51M-19.89%-11.44M-27.91%-3.02M-5.93%-3.2M-23.82%-2.66M-27.27%-2.57M-7.33%-9.54M-18.20%-2.36M-26.99%-3.02M7.74%-2.15M
Basic earnings per share -16.67%-0.070.00%-0.25-16.67%-0.0712.50%-0.070.00%-0.06-20.00%-0.0619.35%-0.2514.29%-0.060.00%-0.0825.00%-0.06
Diluted earnings per share -16.67%-0.070.00%-0.25-16.67%-0.0712.50%-0.070.00%-0.06-20.00%-0.0619.35%-0.2514.29%-0.060.00%-0.0825.00%-0.06
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +20.00%
Sample Name
Sample Code
 +12.40%
Sample Name
Sample Code
 +11.01%
4
Powershares Db Multi-Sector Commodi Powershares Db Oil Fund
DBO
+8.22%
5
United States Oil Fund LP
USO
+7.03%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +19.20%
Sample Name
Sample Code
 +18.16%
Sample Name
Sample Code
 +12.05%
4
KE Holdings
BEKE
+10.61%
5
ASE Technology
ASX
+8.36%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 7 Eastern Time, as the US-Iran negotiations entered a critical window amid external expectations and various parties' strategic maneu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -